The emergence of a new discipline, hepatobiliary oncology^†

• Pages: 365-366
• First Published: 26 January 2008

• Pages: 367-369
• First Published: 26 January 2008

Transient elastography in acute hepatitis: All that's stiff is not fibrosis^†‡

• Pages: 370-372
• First Published: 26 January 2008

The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitis^†‡

• Pages: 373-375
• First Published: 26 January 2008

Sex hormones and bile acids in intrahepatic cholestasis of pregnancy^†‡

• Pages: 376-379
• First Published: 26 January 2008

Acute viral hepatitis increases liver stiffness values measured by transient elastography^†

• Pages: 380-384
• First Published: 26 January 2008

Cell culture–produced hepatitis C virus impairs plasmacytoid dendritic cell function^†

• Pages: 385-395
• First Published: 26 January 2008

• Pages: 396-406
• First Published: 26 January 2008

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus^†

• Pages: 407-417
• First Published: 26 January 2008

Hepatitis C virus receptor expression in normal and diseased liver tissue^†

• Pages: 418-427
• First Published: 26 January 2008

• Pages: 428-434
• First Published: 26 January 2008

Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus^†

• Pages: 435-446
• First Published: 26 January 2008

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial^†‡

• Pages: 447-454
• First Published: 26 January 2008

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers^†

• Pages: 455-460
• First Published: 26 January 2008

Activation of peroxisome proliferator-activated receptor-α inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia–reperfusion^†

• Pages: 461-472
• First Published: 26 January 2008

Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo^†

• Pages: 473-483
• First Published: 26 January 2008

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease^†

• Pages: 484-492
• First Published: 26 January 2008

Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma^†

• Pages: 493-502
• First Published: 26 January 2008

Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma^†

• Pages: 503-510
• First Published: 26 January 2008

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis^†

• Pages: 511-520
• First Published: 26 January 2008

Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β^†‡

• Pages: 521-531
• First Published: 26 January 2008

Blocking α2 integrins on rat CC531s colon carcinoma cells prevents operation-induced augmentation of liver metastases outgrowth^†

• Pages: 532-543
• First Published: 26 January 2008

Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine^†

• Pages: 544-551
• First Published: 26 January 2008

Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion^†

• Pages: 552-562
• First Published: 26 January 2008

Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis^†

• Pages: 563-570
• First Published: 26 January 2008

Natural killer T cells exacerbate liver injury in a transforming growth factor β receptor II dominant-negative mouse model of primary biliary cirrhosis^†

• Pages: 571-580
• First Published: 26 January 2008

Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis^†

• Pages: 581-591
• First Published: 26 January 2008

Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage^†

• Pages: 592-595
• First Published: 26 January 2008

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy^†‡

• Pages: 596-604
• First Published: 26 January 2008

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial^†‡

• Pages: 605-612
• First Published: 26 January 2008

S-adenosylmethionine prevents mallory denk body formation in drug-primed mice by inhibiting the epigenetic memory^†

• Pages: 613-624
• First Published: 26 January 2008

Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis^†

• Pages: 625-635
• First Published: 26 January 2008

Identification of adult hepatic progenitor cells capable of repopulating injured rat liver^†

• Pages: 636-647
• First Published: 26 January 2008

Therapeutic RNA silencing of Cys-X3-Cys chemokine ligand 1 gene prevents mice from adenovirus vector-induced acute liver injury^†

• Pages: 648-658
• First Published: 26 January 2008

The methionine connection: Homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats^†

• Pages: 659-667
• First Published: 26 January 2008

Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells^†

• Pages: 668-676
• First Published: 26 January 2008

High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate–activated protein kinase^†

• Pages: 677-685
• First Published: 26 January 2008

Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes^†‡

• Pages: 686-697
• First Published: 26 January 2008

Characterization of ionotrophic purinergic receptors in hepatocytes^†

• Pages: 698-705
• First Published: 26 January 2008

• Pages: 706-718
• First Published: 26 January 2008

Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development^†

• Pages: 719-728
• First Published: 26 January 2008

Liver: An organ with predominant innate immunity^†

• Pages: 729-736
• First Published: 26 January 2008

The causes of primary biliary cirrhosis: Convenient and inconvenient truths^†

• Pages: 737-745
• First Published: 26 January 2008

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach^†‡

• Pages: 746-754
• First Published: 26 January 2008

The inhaled route to improved liver function^†

• Pages: 755-756
• First Published: 26 January 2008

“Peptide-based NASH therapy, a first crucial step - soon clinical reality?”^†

• Pages: 757-758
• First Published: 26 January 2008

Nonalcoholic steatohepatitis in chronic hepatitis C: A new classification?^†

• Page: 759
• First Published: 26 January 2008

Reply:^†

• Pages: 759-760
• First Published: 26 January 2008

Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?^†

• Pages: 760-761
• First Published: 26 January 2008

Reply:^†

• Page: 761
• First Published: 26 January 2008

The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases^†

• Pages: 762-763
• First Published: 26 January 2008

Predictive value of FIB-4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C^†

• Page: 763
• First Published: 26 January 2008

Leptin, a possible cause for regulatory T cell loss in fatty liver?^†

• Page: 764
• First Published: 26 January 2008

Reply:^†

• Page: 764
• First Published: 26 January 2008

Lipid accumulation in concanavalin A-induced hepatitis: Another cause for impaired liver regeneration afterwards?^†

• Page: 765
• First Published: 26 January 2008

Reply:^†

• Pages: 765-766
• First Published: 26 January 2008

Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naïve chronically infected patient^†

• Pages: 766-767
• First Published: 26 January 2008

• Page: 768
• First Published: 26 January 2008

• Page: 769
• First Published: 26 January 2008

• Page: 769
• First Published: 26 January 2008

• Page: 769
• First Published: 26 January 2008